{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:53:49Z","timestamp":1776650029034,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"\u201cBrigitta und Norbert Muth Stiftung, Wiesbaden, Germany\u201d"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ctim.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:36:02Z","timestamp":1551872162000},"page":"295-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration"],"prefix":"10.1016","volume":"43","author":[{"given":"Jens","family":"Mani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Maxeiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Juengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Bon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.-H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman A.","family":"Blaheta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000464248","article-title":"Complementary and alternative medicine: a clinical study in 1,016 hematology\/oncology patients","volume":"93","author":"Hierl","year":"2017","journal-title":"Oncology"},{"key":"10.1016\/j.ctim.2019.03.002_bib0010","first-page":"422","article-title":"Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients","volume":"52","author":"Schieman","year":"2009","journal-title":"Can J Surg"},{"key":"10.1016\/j.ctim.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1177\/014556131008901005","article-title":"Prevalence of complementary and alternative medicine use among a population of head and neck cancer patients: A survey-based study","volume":"89","author":"Miller","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.ctim.2019.03.002_bib0020","unstructured":"National Center of Complementary and Integrative Health. https:\/\/nccih.nih.gov\/. Accessed 01 March 2019."},{"key":"10.1016\/j.ctim.2019.03.002_bib0025","unstructured":"BfArM 2015. http:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/Gremien\/RoutinesitzungPar63AMG\/74Sitzung\/pkt-4-3.pdf?__blob=publicationFile&v=1. Accessed 14 August 2018."},{"key":"10.1016\/j.ctim.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0006-2952(86)90580-0","article-title":"Intestinal first pass metabolism of amygdalin in the rat in vitro","volume":"35","author":"Strugala","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ctim.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.phytochem.2003.10.016","article-title":"Cyanogenic glucosides and plant-insect interactions","volume":"65","author":"Zagrobelny","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ctim.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phymed.2016.02.004","article-title":"Amygdalin, quackery or cure?","volume":"23","author":"Blaheta","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ctim.2019.03.002_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM198201283060403","article-title":"A clinical trial of amygdalin (Laetrile) in the treatment of human cancer","volume":"306","author":"Moertel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2019.03.002_bib0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.1981.03310310033018","article-title":"A pharmacologic and toxicological study of amygdalin","volume":"245","author":"Moertel","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.ctim.2019.03.002_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00253010","article-title":"Pharmacology of amygdalin (laetrile) in cancer patients","volume":"6","author":"Ames","year":"1981","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ctim.2019.03.002_bib0060","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/SAP.0000000000001351","article-title":"Carbon monoxide and cyanide poisoning in the burned pregnant patient: An indication for hyperbaric oxygen therapy","volume":"80","author":"Culnan","year":"2018","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ctim.2019.03.002_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MEJ.0b013e328357170b","article-title":"Cyanide poisoning by fire smoke inhalation: A European expert consensus","volume":"20","author":"Anseeuw","year":"2013","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.ctim.2019.03.002_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10354-014-0340-7","article-title":"Severe cyanide poisoning from an alternative medicine treatment with amygdalin and apricot kernels in a 4-year-old child","volume":"165","author":"Sauer","year":"2015","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.ctim.2019.03.002_bib0075","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.1978.03280420068022","article-title":"Rapid death associated with laetrile ingestion","volume":"239","author":"Sadoff","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.ctim.2019.03.002_bib0080","first-page":"175","article-title":"Initial pharmacologic studies of amygdalin (laetrile) in man","volume":"22","author":"Ames","year":"1978","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.ctim.2019.03.002_bib0085","first-page":"97","article-title":"Amygdalin toxicity studies in rats predict chronic cyanide poisoning in humans","volume":"134","author":"Newton","year":"1981","journal-title":"West J Med"},{"key":"10.1016\/j.ctim.2019.03.002_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2009.06.024","article-title":"Possible contribution of beta-glucosidase and caspases in the cytotoxicity of glufosfamide in colon cancer cells","volume":"616","author":"Arafa","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ctim.2019.03.002_bib0095","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1039\/C2DT32429F","article-title":"Glycosylated copper(II) ionophores as prodrugs for \u03b2-glucosidase activation in targeted cancer therapy","volume":"42","author":"Oliveri","year":"2013","journal-title":"Dalton Trans"},{"key":"10.1016\/j.ctim.2019.03.002_bib0100","series-title":"Cyanogenic glycosides","author":"Speijers","year":"2015"},{"key":"10.1016\/j.ctim.2019.03.002_bib0105","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/CCM.0000000000003075","article-title":"Determinants of lactic acidosis in acute cyanide poisonings","volume":"46","author":"Baud","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ctim.2019.03.002_bib0110","first-page":"2788","article-title":"Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si\u2011SATB1 in ovarian cancer","volume":"40","author":"Xiang","year":"2018","journal-title":"Oncol Rep"},{"issue":"Supplement","key":"10.1016\/j.ctim.2019.03.002_bib0115","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.4103\/0973-1482.168994","article-title":"Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer","volume":"14","author":"Chen","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ctim.2019.03.002_bib0120","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1159\/000493110","article-title":"Increased lactate in gastric Cancer Tumor-Infiltrating lymphocytes is related to impaired t cell function due to miR-34a deregulated lactate dehydrogenase a","volume":"49","author":"Ping","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ctim.2019.03.002_bib0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lfs.2018.07.027","article-title":"Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction","volume":"208","author":"Jia","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.ctim.2019.03.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27257","article-title":"Clinical significance of MYCN amplification in patients with high-risk neuroblastoma","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ctim.2019.03.002_bib0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopha.2018.09.031","article-title":"PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis","volume":"108","author":"Cheng","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ctim.2019.03.002_bib0140","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbrc.2018.03.079","article-title":"Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming","volume":"498","author":"Ma","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ctim.2019.03.002_bib0145","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.4103\/0973-1482.168994","article-title":"Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer","volume":"14","author":"Chen","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ctim.2019.03.002_bib0150","first-page":"209","article-title":"Five years experience with laetrile therapy in advanced cancer","volume":"15","author":"Navarro","year":"1959","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"10.1016\/j.ctim.2019.03.002_bib0155","first-page":"299","article-title":"Chemotherapy of Inoperable Cancer. Preliminary Report of 10 Cases Treated with Laetrile","volume":"20","author":"Morrone","year":"1962","journal-title":"Exp Med Surg"},{"key":"10.1016\/j.ctim.2019.03.002_bib0160","article-title":"A clinical trial of chemotherapeutic treatment of advanced cancers with L- mandelonitrile \u03b2- diglucoside (abstract)","author":"Rossi","year":"1966","journal-title":"9th International Cancer Congress"},{"key":"10.1016\/j.ctim.2019.03.002_bib0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJM198207083070213","article-title":"Laetrile","volume":"307","author":"Correspondence (no authors listed)","year":"1982","journal-title":"N. Engl. J. Med."}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919302122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919302122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:12:02Z","timestamp":1760807522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229919302122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"alternative-id":["S0965229919302122"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2019.03.002","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyanide and lactate levels in patients during chronic oral amygdalin intake followed by intravenous amygdalin administration","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}